Business Eli Lilly to Spend $4 Billion on Vaccine Developers by mark.thompson business editor May 26, 2026 by mark.thompson business editor May 26, 2026 Read more 0 FacebookTwitterPinterestEmail
Business Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound? by mark.thompson business editor May 17, 2026 by mark.thompson business editor May 17, 2026 Read more 0 FacebookTwitterPinterestEmail
Health Retatrutide: Eli Lilly’s Next-Gen Triple-Agonist for Weight Loss and Diabetes by Grace Chen April 12, 2026 by Grace Chen April 12, 2026 Read more 0 FacebookTwitterPinterestEmail
Health Mounjaro Leads India’s Obesity Drug Market as Semaglutide Generics Surge by Grace Chen April 9, 2026 by Grace Chen April 9, 2026 Read more 0 FacebookTwitterPinterestEmail
World Generic Ozempic and Wegovy Hit India and China After Patent Expiry by Ahmed Ibrahim World Editor April 9, 2026 by Ahmed Ibrahim World Editor April 9, 2026 Read more 0 FacebookTwitterPinterestEmail
Business FDA Approves Foundayo: Eli Lilly’s New Weight Loss Pill by Ahmed Ibrahim World Editor April 3, 2026 by Ahmed Ibrahim World Editor April 3, 2026 Read more 0 FacebookTwitterPinterestEmail
